AK Anam, K Insogna - Medical Clinics, 2021 - medical.theclinics.com
Osteoporosis is a metabolic bone disease characterized by low bone mass and microarchitectural deterioration of the bone tissue, leading to reduced bone strength and …
Bone loss in space travelers is a major challenge for long-duration space exploration. To quantify microgravity-induced bone loss in humans, we performed a meta-analysis of …
Y Zhou, Y Deng, Z Liu, M Yin, M Hou, Z Zhao… - Science …, 2021 - science.org
Imbalance between osteoblasts and osteoclasts accounts for the incidence and deterioration of postmenopausal osteoporosis. Abnormally elevated RANKL and TNF-α …
J Behera, J Ison, MJ Voor, N Tyagi - Diabetes, 2022 - Am Diabetes Assoc
Recent evidence suggests that physical exercise (EX) promotes skeletal development. However, the impact of EX on the progression of bone loss and deterioration of mechanical …
P Szulc - Best practice & research Clinical endocrinology & …, 2018 - Elsevier
Bone turnover includes two processes: resorption (removal of old bone) and formation (laying down of new bone). N-terminal propeptide of type I procollagen (PINP) and C …
B Adejuyigbe, J Kallini, D Chiou, JR Kallini - International journal of …, 2023 - mdpi.com
Osteoporosis is a major public health concern affecting millions of people worldwide and resulting in significant economic costs. The condition is characterized by changes in bone …
KY Chin, BN Ng, MKI Rostam… - Journal of Clinical …, 2022 - mdpi.com
Osteoporosis refers to excessive bone loss as reflected by the deterioration of bone mass and microarchitecture, which compromises bone strength. It is a complex multifactorial …
Background Biochemical markers of bone turnover (BTMs), such as bone alkaline phosphatase (bALP), procollagen type IN propeptide (PINP), serum cross-linked C …
Background Biochemical markers of bone turnover (BTMs), such as the bone alkaline phosphatase (bALP), procollagen type IN propeptide (PINP), serum cross-linked C …